筋肉の衰弱
1Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA. Yeo.Dongwook@mayo.edu.
Advances in experimental medicine and biology
|August 29, 2025
まとめ
筋肉の衰弱は 筋肉の質量と力の喪失で 多くの患者に影響します この状態と闘うために 耐性トレーニングを超えた 分子メカニズムと新しい治療法を 研究しています
科学分野:
- 生理学
- 分子生物学
- ゲロントロジー
背景:
- 筋肉の衰弱は,非活動性による骨格筋の質量と強さの減少を伴う.
- 年齢や栄養不良により悪化する 肢体不動や脊髄損傷の患者でよく見られる.
- 後肢の脱荷のようなネズミのモデルは 筋肉の劣化メカニズムを理解しています
研究 の 目的:
- 分子と細胞の経路を要約して 筋肉の代謝を制御する
- 筋肉の衰弱に対する現在および新興の治療戦略をレビューする.
- 筋肉の衰えが 生活の質や身体機能に与える影響を 強調するためです
主な方法:
- 歯類のモデル (後肢の解体,不動化,神経切除,脊髄分離) のレビュー
- 筋肉のタンパク質分解の分子と細胞のメカニズムを分析する.
- 抵抗訓練と新しい治療介入に関する既存の文献の統合.
主要な成果:
- 分子信号と筋疲労を引き起こす経路の詳細な理解
- レジスタンス・トレーニングは有効だが,一部の患者には限られている.
- 新興の薬理学的および非薬理学的戦略は,予防と回復の見込みを示しています.
結論:
- 筋肉の衰弱は 複雑な分子基盤を持ち 重要な臨床的影響を及ぼします
- 現在の治療法は限られており,代替治療法の研究が必要である.
- 将来の戦略は 縮を防ぐか 回復を促進し 患者の成果と生活の質を改善することを目指しています
関連する概念動画
Cross-bridge Cycle
118.2K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.2K
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Muscle Recovery and Fatigue
2.5K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.5K
Chemical Synapses
9.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.1K


